| A Study of Anti-PD-1 AK105 in Patients With Relapsed or Refractory Classic Hodgkin Lymphoma (NCT03722147) | Akeso | 2018-08-13 |
| Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma (NCT03452930) | M.D. Anderson Cancer Center | 2018-08-13 |
| A Study to Test Safety, Tolerability, and the Way the Body Absorbs, Distributes, and Gets Rid of a Study Drug Called MOR106, in Healthy Subjects and in Patients With Moderate to Severe Atopic Dermatitis (NCT03689829) | Lakefront Biotherapeutics NV | 2018-08-13 |
| A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors (NCT03486314) | Millennium Pharmaceuticals, Inc. | 2018-08-13 |
| A Study to Evaluate Scales for Repetitive and Restricted Behaviors in Children, Adolescents, and Adults With Autism Spectrum Disorder (ASD) (NCT03611075) | Hoffmann-La Roche | 2018-08-13 |
| A Study of MSB2311 in Advanced Solid Tumors (NCT04272944) | Suzhou Transcenta Therapeutics Co., Ltd. | 2018-08-13 |
| Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001) (NCT03515824) | Merck Sharp & Dohme LLC | 2018-08-13 |
| Prospective Study on the Efficacy and Safety of 2 Week or 3 Week Xelox Regimen for Adjuvant Chemotherapy in CRC (NCT03564912) | Zhejiang University | 2018-08-12 |
| Evaluate Safety, Tolerability and Pharmacokinetics of Fadanafil （XZP-5849）in Chinese Healthy Adult Male Subjects (NCT04312568) | Sihuan Pharmaceutical Holdings Group Ltd. | 2018-08-10 |
| QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. (NCT03552718) | NantBioScience, Inc. | 2018-08-10 |
| Imaging With a PET Agent for Detection of Cancers of the Head and Neck (NCT03631017) | Memorial Sloan Kettering Cancer Center | 2018-08-10 |
| Plasmodium Immunotherapy for Breast and Liver Cancers (NCT03474822) | CAS Lamvac Biotech Co., Ltd. | 2018-08-10 |
| Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer (NCT03455556) | Mayo Clinic | 2018-08-10 |
| Ketamine for Treatment of MS Fatigue (NCT03500289) | Johns Hopkins University | 2018-08-10 |
| A Phase I Study of SB Cell for the Enhanced Osseointegration of Guided Bone Regeneration in Implant Surgery (NCT04451486) | Taipei Medical University | 2018-08-10 |
| A Study of HS-196, an HSP90 Inhibitor-linked NIR Probe for Solid Malignancies (NCT03333031) | Herbert Lyerly | 2018-08-10 |
| Antibacterial Effect of Light-activated Calcium Silicate Versus Light-activated Calcium Hydroxide (NCT03214770) | Cairo University | 2018-08-10 |
| Study of LY3154207 in Healthy Participants (NCT03616795) | Eli Lilly and Company | 2018-08-09 |
| A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects (NCT03609606) | Chong Kun Dang Pharmaceutical | 2018-08-09 |
| Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis (NCT03278925) | National Cancer Institute (NCI) | 2018-08-09 |
| Phase I Study to Assess Irritation, Sensitization and Adhesion of a Novel Ibuprofen 200 mg TEPI Medicated Plaster (NCT03639571) | Medherant Ltd | 2018-08-09 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis (NCT03630939) | Escalier Biosciences B.V. | 2018-08-09 |
| First Research Study of the Possible New Medicine NNC0113-2023 in Healthy Men. (NCT03617081) | Novo Nordisk A/S | 2018-08-09 |
| Effects of Trunk Exercise on Trunk Control and Balance in Persons With Stroke (NCT04434443) | National Cheng Kung University | 2018-08-09 |
| A Study of A166 in Patients With Advanced Solid Malignant Tumors (NCT05311397) | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 2018-08-09 |
| Pharmacokinetic Study of Ravulizumab Administered Subcutaneously With Recombinant Human Hyaluronidase PH20 (rHuPH20) in Healthy Adult Volunteers (NCT05396742) | Alexion Pharmaceuticals, Inc. | 2018-08-09 |
| Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel (NCT03653403) | Bausch Health Americas, Inc. | 2018-08-08 |
| BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL) (NCT03576378) | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | 2018-08-08 |
| The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors. (NCT03577704) | Shanghai Henlius Biotech | 2018-08-08 |
| This Study Aims to Find and Test a Safe Dose of BI 905677 in Patients With Different Types of Cancer (Solid Tumours) (NCT03604445) | Boehringer Ingelheim | 2018-08-08 |
| Pharmacokinetics and Safety Profile of CKD-333 (NCT03659149) | Chong Kun Dang Pharmaceutical | 2018-08-08 |
| Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma (NCT03376659) | Georgetown University | 2018-08-08 |
| Effect of Food on the Pharmacokinetics of TEW-7197 in Healthy Subjects (NCT03704675) | MedPacto, Inc. | 2018-08-08 |
| A Trial to Compare Blood Concentration Levels of Semaglutide Following Subcutaneous Injections of Semaglutide 1 mg by 2 Different Devices (the DV3372 Device and by the PDS290 Semaglutide Pen-injector) (NCT03611322) | Novo Nordisk A/S | 2018-08-08 |
| Neural Correlates of Driving and Cannabis (NCT03581058) | Unity Health Toronto | 2018-08-08 |
| A Phase 1 Study of HLX20, a Human Monoclonal Antibody Targeting PD-L1Protein in Patients With Advanced Solid Tumors (NCT03588650) | Shanghai Henlius Biotech | 2018-08-07 |
| A Study to Demonstrate Bioequivalence Between Lorcaserin Extended Release (XR) Tablets Manufactured in Kawashima and Lorcaserin XR Tablets Manufactured in Zofingen in Healthy Participants (NCT03627936) | Eisai Inc. | 2018-08-07 |
| The Safety and Tolerability of Alprostadil Liposome for Injection in Healthy Adult Volunteers (NCT03669562) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2018-08-07 |
| Cycloserine rTMS Plasticity Augmentation (NCT03432689) | University of Calgary | 2018-08-06 |
| A Single Dose of Pembrolizumab in HIV-Infected People (NCT03367754) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-08-06 |
| A Study to Assess the Safety, Tolerability and Pharmacokinetics of Subcutaneous (SC) Injections of JNJ-64565111 in Healthy Male Japanese Participants and to Assess Pharmacokinetics Following Subcutaneous Injections of JNJ-64565111 in Healthy Male Caucasian Participants (NCT03618160) | Janssen Pharmaceutical K.K. | 2018-08-06 |
| A Study of the Safety and Effect of Repeated Administration of G-CSF on Hot Flashes in Postmenopausal Women (NCT03640754) | MenoGeniX, Inc. | 2018-08-06 |
| PD-1 Antibody Expressing mesoCAR-T Cells for Mesothelin Positive Advanced Solid Tumor (NCT03615313) | Shanghai Cell Therapy Research Institute | 2018-08-06 |
| Pharmacokinetic Study of E7080/Lenvatinib in Chinese Subjects With Solid Tumor (NCT03009292) | Eisai Co., Ltd. | 2018-08-06 |
| Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral Therapy (NCT03208231) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-08-06 |
| Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies (NCT03637764) | Sanofi | 2018-08-06 |
| Absolute Bioavailability and Metabolism Study of CORT118335 in Healthy Male Participants (NCT03878264) | Corcept Therapeutics | 2018-08-06 |
| A Study in Healthy Japanese Men to Test How Different Doses of BI 690517 Are Taken Up in the Body and How Well They Are Tolerated (NCT03608072) | Boehringer Ingelheim | 2018-08-06 |
| Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase (NCT03531320) | InnoPharmax Inc. | 2018-08-06 |
| Safety and Tolerability of INP105 (Olanzapine by I231 POD® Device) Nasal Spray in Healthy Volunteers - SNAP 101 (NCT03624322) | Impel Pharmaceuticals | 2018-08-05 |
| Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production (NCT03551769) | Cerecin | 2018-08-05 |
| Sickness Evaluation at Altitude With Acetazolamide at Relative Dosages (NCT03424226) | Stanford University | 2018-08-04 |
| MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer (NCT03634267) | M.D. Anderson Cancer Center | 2018-08-03 |
| A Study in Evaluating Bioequivalence of Test and Reference Vadadustat 450 MG and 150 MG Tablets and to Determine Food Effect on the 450 MG Tablet (NCT03657290) | Akebia Therapeutics | 2018-08-03 |
| Radial Artery Vasodilation Heat Study (NCT03620383) | Oregon Health and Science University | 2018-08-03 |
| Study to Compare 2 Formulations of LY900014 in Healthy Participants (NCT03616977) | Eli Lilly and Company | 2018-08-03 |
| Study of LYC-55716 With Pembrolizumab in Adult Subjects With Non-Small Cell Lung Cancer (NCT03396497) | Lycera Corp. | 2018-08-03 |
| Study of 6b11-OCIK Injection Treatment in Patients With Recurrent Drug-resistant Ovarian Cancer (NCT03542669) | Peking University People's Hospital | 2018-08-03 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD8233 in Healthy Male Subjects With Increased Elevated LDL-C Levels. (NCT03593785) | AstraZeneca | 2018-08-03 |
| Can Imagination Change Upsetting Memories of Trauma? (NCT03607630) | King's College London | 2018-08-03 |
| M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer (NCT03620201) | M.D. Anderson Cancer Center | 2018-08-03 |
| Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With TriCAR-T_CD19 (NCT03497533) | Timmune Biotech Inc. | 2018-08-03 |
| Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC (NCT03370406) | Melissa Pugliano-Mauro | 2018-08-03 |
| PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer (NCT05732948) | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | 2018-08-02 |
| CD19 Chimeric Antigen Receptors and CD19 Positive Feeder T Cells as a Leukemia Consolidation Treatment (NCT05381662) | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | 2018-08-02 |
| Liver Glycogen and Hypoglycemia in Humans (NCT03241706) | Jason Winnick | 2018-08-02 |
| T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias (NCT03653338) | Paul Szabolcs | 2018-08-02 |
| Single Ascending Oral Doses of SY-008 in Healthy Subjects (NCT03462589) | Suzhou Yabao Pharmaceutical R&D Co., Ltd. | 2018-08-02 |
| A Study of INCB050465 in Japanese Subjects With Previously Treated B-Cell Lymphoma (CITADEL-111) (NCT03314922) | Incyte Corporation | 2018-08-02 |
| Prospective Study in Adults Evaluating Safety & Efficacy of NVD003 for Bone Reconstruction to Treat Lower Limb Nonunion (NCT06335394) | Novadip Biosciences | 2018-08-02 |
| Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer (NCT03523572) | Daiichi Sankyo | 2018-08-02 |
| A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Psoriasis (NCT03710681) | Jiangsu HengRui Medicine Co., Ltd. | 2018-08-02 |
| Midodrine in Hepatopulmonary Syndrome (NCT03600870) | Mayo Clinic | 2018-08-02 |
| A Study of Safety, Tolerability, and Pharmacokinetics of Single Doses of PHP-303 in Healthy Subjects (NCT03627845) | pH Pharma | 2018-08-02 |
| A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma (NCT03605550) | Nationwide Children's Hospital | 2018-08-01 |
| A Study of IPL344 in the Treatment of ALS Patients (NCT03652805) | Immunity Pharma Ltd. | 2018-08-01 |
| A Study of LioCyx in Patient With Recurrent HBV-related HCC Post Liver Transplantation (NCT03634683) | Lion TCR Pte. Ltd. | 2018-08-01 |
| Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children (NCT03111069) | M.D. Anderson Cancer Center | 2018-08-01 |
| CD19 CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia (NCT03854994) | Yan'an Affiliated Hospital of Kunming Medical University | 2018-08-01 |
| Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC) (NCT02756130) | Jonsson Comprehensive Cancer Center | 2018-08-01 |
| A Study of Absorption, Metabolism, Excretion, and Absolute Bioavailability of Carbon-14-Labelled [14C] Selpercatinib (LY3527723) in Healthy Male Participants (NCT05630287) | Eli Lilly and Company | 2018-08-01 |
| QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC (NCT03169777) | ImmunityBio, Inc. | 2018-08-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of NV1205 in Pediatric Male Subjects With Adrenoleukodystrophy (NCT03196765) | NeuroVia, Inc. | 2018-08-01 |
| Scopolamine in Healthy Volunteers (NCT03874130) | Repurposed Therapeutics, Inc. | 2018-08-01 |
| CD19-CART Treatment for ALL (NCT03232619) | Bioray Laboratories | 2018-08-01 |
| Absolute Bioavailability Study With Bexagliflozin (NCT03417076) | Theracos | 2018-08-01 |
| Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris (NCT03662685) | University of California, San Francisco | 2018-08-01 |
| Adoptive T Cell Therapy in Patients With Recurrent Ovarian Cancer (NCT04072263) | Leiden University Medical Center | 2018-08-01 |
| Treatment of Tumors in the Urinary Collecting System of the Kidney or Ureter Using a Light Activated Drug (WST11) (NCT03617003) | Memorial Sloan Kettering Cancer Center | 2018-08-01 |
| A Phase I Study of FCN-411 in Advanced Non-small Cell Lung Cancer Chinese Patients With EGFR Positive Mutation (NCT03420079) | Ahon Pharmaceutical Co., Ltd. | 2018-08-01 |
| Influence of Cola on the Absorption of the HCV Agent Velpatasvir in Combination With PPI Omeprazole. (NCT03513393) | Radboud University Medical Center | 2018-08-01 |
| MAX-40279 in Subjects With Acute Myelogenous Leukemia (AML) (NCT03412292) | Maxinovel Pty., Ltd. | 2018-08-01 |
| Umbilical Cord Blood Mononuclear Cells for Hypoxic Neurologic Injury in Infants With Congenital Diaphragmatic Hernia (CDH) (NCT03526588) | The University of Texas Health Science Center, Houston | 2018-08-01 |
| Therapeutic Vaccination in Treated HIV Disease (NCT03606213) | Steven Deeks | 2018-08-01 |
| A Study of RX108 in Patients With Locally Advanced or Metastatic Solid Tumors (NCT03646071) | NeuPharma, Inc. | 2018-08-01 |
| Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients (NCT03535545) | Massachusetts General Hospital | 2018-08-01 |
| Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma (NCT06562621) | Beijing Neurosurgical Institute | 2018-08-01 |
| Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells (NCT03554889) | Hangzhou Cancer Hospital | 2018-08-01 |
| Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma (NCT04303403) | National Cancer Centre, Singapore | 2018-07-31 |
| This Study in Healthy Men Tests How Different Doses of BI 1323495 Are Taken up in the Body and How Well They Are Tolerated. (NCT03588390) | Boehringer Ingelheim | 2018-07-31 |